In a multicenter study published in the December issue of The American Journal of Gastroenterology, researchers divided more than 1,000 consecutive patients undergoing total colonoscopy into IBS and non-IBS groups and compared characteristics. IBS was diagnosed using Rome III criteria, and diverticulosis was diagnosed by colonoscopy with transparent soft-short-hood. Data showed that the presence of left-sided and bilateral diverticular disease (DD), but not right-sided disease, was associated with a higher risk of IBS. Read the abstract.
Elke Arendt, a college professor in Ireland, says creating palatable gluten-free products is difficult, but he thinks sourdough has potential to produce gluten-free bread with acceptable flavor and structure. Investment in research and development of gluten-free products is increasing.
A late-stage trial on the use of aflibercept in combination with gemcitabine as first-line treatment of pancreatic cancer was discontinued because of disappointing results. The drugmakers said they will continue testing aflibercept's effectiveness against metastatic colorectal cancer, metastatic prostate cancer and nonsmall-cell lung cancer.
There is a lot of talk about probiotic use for digestive health, but as with any supplement, you need to know what you're taking and why. The healthy digestive tract bacteria often are credited with improving lactose intolerance, diarrhea, irritable bowel syndrome, Crohn's disease and other conditions. So far, research has only shown probiotics help with diarrhea and may aid in improving lactose intolerance symptoms.
Most people who use probiotics are hoping to improve their digestive system, for conditions ranging from lactose intolerance and antibiotics-related diarrhea to irritable bowel syndrome and inflammatory bowel disease. More companies are launching pills, foods and other products that claim health benefits from probiotics.